National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

paclitaxel poliglumex (PA-klih-TAK-sil PAH-lee-GLOO-mex)

 A form of the anticancer drug paclitaxel combined with a protein called poliglumex that may have fewer side effects and work better than paclitaxel. It is being studied in the treatment of breast cancer, ovarian cancer, lung cancer, and other types of cancer. It belongs to the family of drugs called mitotic inhibitors. Also called CT-2103, paclitaxel polyglutamate, and Xyotax.



Previous Definitions:Pacific valerian, pack year, paclitaxel, paclitaxel albumin-stabilized nanoparticle formulation, paclitaxel liposome
Next Definitions:paclitaxel polyglutamate, Paget disease of bone, Paget disease of the nipple, pain threshold, PALA

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov